Praxis fr Neurologie und Psychiatrie Dr. Christian Oehlwein

Research site

Germany Lasurstr. 27, 07551 Gera, Germany

Dementia Alzheimer's type · Parkinson's disease
Adult patients

About Specializations

Praxis fr Neurologie und Psychiatrie Dr. Christian Oehlwein in Gera, Germany specialises in clinical trials of conditions such as Dementia Alzheimer's type, Parkinson's disease, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Lasurstr. 2707551 GeraGermany

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in Gera Germany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Dementia Alzheimer's type

Not recruiting

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Quinidine Sulfate
Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Contact Research Centre

Parkinson's disease

Not recruiting

Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson's Disease

Registered drugNo placebo

Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson's Disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Rotigotine
Sponsor:Luye Pharma Switzerland AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites